Artwork

Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Psychedelics, placebo, and anesthetic dreams | Boris Heifets (part 1)

30:27
 
Share
 

Manage episode 415977407 series 3435707
Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelics are a hot topic in psychiatry today. They’re producing dramatic reversals for patients with severe depression, PTSD, and other mental health conditions. But scientists still have fundamental questions about why these drugs are so effective.
For example, is the "trip" even necessary? Some think it is not and are working to design drugs with similar brain chemistry but no psychoactive effects — “Taking the trip out of the drug.”
Others suspect that many of the benefits of psychedelics can be attributed to hype and expectation: People expect to get better, so they do.
Normally scientists control for placebo using a blinded study where patients don't know if they're getting the real treatment or a sugar pill. But how are you going to do this with mind-altering substances? Patients are probably going to figure out pretty quickly whether they got a sugar cube with or without LSD.
Today's guest, Stanford anesthesiologist Boris Heifets, has come up with a particularly clever strategy to tease apart the psychedelic experience, biochemistry, hype and placebo.
Listen for the whole story!

Learn more:

Depression, ketamine & anesthesia:

Anesthetic dreams and trauma recovery:

Related episodes:

Episode credits
This episode was produced by

Send us a text!

Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.
Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

  continue reading

33 episodes

Artwork
iconShare
 
Manage episode 415977407 series 3435707
Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelics are a hot topic in psychiatry today. They’re producing dramatic reversals for patients with severe depression, PTSD, and other mental health conditions. But scientists still have fundamental questions about why these drugs are so effective.
For example, is the "trip" even necessary? Some think it is not and are working to design drugs with similar brain chemistry but no psychoactive effects — “Taking the trip out of the drug.”
Others suspect that many of the benefits of psychedelics can be attributed to hype and expectation: People expect to get better, so they do.
Normally scientists control for placebo using a blinded study where patients don't know if they're getting the real treatment or a sugar pill. But how are you going to do this with mind-altering substances? Patients are probably going to figure out pretty quickly whether they got a sugar cube with or without LSD.
Today's guest, Stanford anesthesiologist Boris Heifets, has come up with a particularly clever strategy to tease apart the psychedelic experience, biochemistry, hype and placebo.
Listen for the whole story!

Learn more:

Depression, ketamine & anesthesia:

Anesthetic dreams and trauma recovery:

Related episodes:

Episode credits
This episode was produced by

Send us a text!

Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.
Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

  continue reading

33 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide